glp-1/gip receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GLP-1 & GIP Agonists |
Description
Both classic Gs-cAMP/PKA/CREB and alternative Gs-cAMP/PKA/p38/CREB signal pathways mediate exenatide-stimulated expression of M2 microglial markers
Read more about VO max Or strength
Besides promoting weight loss and helping avoid overeating, GLP-1 medications may also offer the following benefits: Improves cardiovascular health: Several GLP-1 agonists may be effective in reducing the risk of cardiovascular disease in people with type 2 diabetes
Why This Matters This approval is a potential inflection point in obesity pharmacotherapy for several reasons: 1
